Search

Displaying results 4221 - 4230 of 7897 in total
  1. Drug

    AAV-AIPL

    go.drugbank.com/drugs/DB17857
    Experimental

    AAV-AIPL is an adenovirus-associated viral vector serotype 8 containing the human _AIPL1_ gene.

  2. Drug

    Inodiftagene vixteplasmid

    go.drugbank.com/drugs/DB16017
    Investigational

    Inodiftagene vixteplasmid is a plasmid DNA vector encoding the diphtheria toxin A (dT-a) gene under transcriptional regulation of the promoter region of the human H19 gene (an imprinted maternally expressed

    Synonyms: dT-A-H19, diphtheria-toxin-A-H19
  3. Drug

    KC706

    go.drugbank.com/drugs/DB05157
    Investigational

    KC706 is a novel anti-inflammatory drug that works by inhibiting the activity of p38 MAP kinase. … KC706 holds potential to treat inflammatory conditions such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and cardiovascular disease.

  4. Drug

    Lofentanil

    go.drugbank.com/drugs/DB09174
    ExperimentalIllicit

    Lofentanil is an analog of fentanyl and is one of the most potent opioids available today.

  5. Drug

    Dexpemedolac

    go.drugbank.com/drugs/DB19987
    Experimental

    Dexpemedolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Dexpemedolac is a anti-inflammatory agent, ibufenac derivative. … Dexpemedolac has a monoisotopic molecular weight of 349.17 Da.

  6. Drug

    Isofezolac

    go.drugbank.com/drugs/DB20228
    Experimental

    Isofezolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Isofezolac is a anti-inflammatory agent, ibufenac derivative. … Isofezolac has a monoisotopic molecular weight of 354.14 Da.

  7. Drug

    Clopirac

    go.drugbank.com/drugs/DB20824
    Experimental

    Clopirac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Clopirac is a anti-inflammatory agent, ibufenac derivative. … Clopirac has a monoisotopic molecular weight of 263.07 Da.

  8. Drug

    AGS-16C3F

    go.drugbank.com/drugs/DB17551
    Investigational

    AGS 16C3F is an intravenously administered, anti-ectonucleotide pyrophosphatase/phosphodiesterase 3 (ENPP3) antibody-drug conjugate. … AGS-16C3F is under investigation in clinical trial NCT02639182 (A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma).

  9. Drug

    EGT-101

    go.drugbank.com/drugs/DB17645
    Experimental

    Developed by Esteve Pharmaceuticals, it is being investigated for Sanfilippo syndrome type A.[L45919] … EGT-101 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of the human sulfamidase (SGSH) transgene.

  10. Drug

    Trofinetide

    go.drugbank.com/drugs/DB06045
    Approved

    [A258453] Trofinetide is marketed as DAYBUE and DAYBUE STIX in the United States, as DAYBUE in Canada, and as DAYBU in the European Union. … Trofinetide is a novel synthetic analog of [glypromate], also known as glycine–proline–glutamate (GPE), a naturally occurring protein in the brain and the N-terminal tripeptide of insulin-like growth factor